Use of IL-17 in the treatment of fertilityrelated disorders

Details for Australian Patent Application No. 2005249504 (hide)

Owner Applied Research Systems ARS Holding N.V.

Inventors Kagan, David; Clark, Ann M.; Palmer, Stephen S.

Agent Griffith Hack

Pub. Number AU-A-2005249504

PCT Pub. Number WO2005/117979

Priority 60/575,326 28.05.04 US

Filing date 31 May 2005

Wipo publication date 15 December 2005

International Classifications

A01N 61/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/117979 Priority application(s): WO2005/117979

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249508-Synthesis of metabolically stable analgesics, pain medications and other agents

2005249503-ICE inhibitors for the treatment of autoinflammatory diseases